Morgan Stanley’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $233K | Buy |
|
|||||
|
2022
Q4 | $46.3K | Sell |
|
|||||
|
2022
Q3 | $131K | Sell |
|
|||||
|
2022
Q2 | $434K | Sell |
|
|||||
|
2022
Q1 | $794K | Sell |
|
|||||
|
2021
Q4 | $2.09M | Buy |
|
|||||
|
2021
Q3 | $1.1M | Sell |
|
|||||
|
2021
Q2 | $2.57M | Buy |
|
|||||
|
2021
Q1 | $33K | Sell |
|
|||||
|
2020
Q4 | $659K | Buy |
|
|||||
|
2020
Q3 | $78K | Sell |
|
|||||
|
2020
Q2 | $2.15M | Buy |
|
|||||
|
2020
Q1 | $50K | Sell |
|
|||||
|
2019
Q4 | $317K | Buy |
|
|||||
|
2019
Q3 | $59K | Buy |
|
|||||
|
2019
Q2 | $1K | Sell |
|
|||||
|
2019
Q1 | $15K | Buy |
|